Question about availability of Lu-177... - Advanced Prostate...

Advanced Prostate Cancer

22,372 members28,135 posts

Question about availability of Lu-177 therapy

mandrake248 profile image
13 Replies

Good news that Lu-177 Infusion treatment is now available to certain PCa patients. Commercial name is PLUVICTO. ..For “adult patients with PSMA-positive metastatic castration resistant prostate cancer who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy.”

My question is: what will be required for FDA approval for earlier stage patients, namely, those who have failed first line treatment (surgery, radiation), but are still castration-sensitive. Will there have to be phase I, phase II and phase III trials?

It’s crazy that this treatment is available in a number of other countries, and has been for a number of years.

Written by
mandrake248 profile image
mandrake248
To view profiles and participate in discussions please or .
Read more about...
13 Replies
Tall_Allen profile image
Tall_Allen

No trials for it for recurrent patients who are still castration sensitive that I'm aware of.

spencoid2 profile image
spencoid2 in reply toTall_Allen

There is one in Santa Barbara CA but I do not qualify because I have been on ADT too long. As with most studies the requirements are very specific. clinicaltrials.gov/ct2/show... To me it is nuts that you have to wait until your cancer is so advanced thatthe treatment is likely to fail instead of treating earlier.

Tall_Allen profile image
Tall_Allen in reply tospencoid2

That is only for newly diagnosed patients. There are none for recurrent patients that I know of.

spencoid2 profile image
spencoid2 in reply toTall_Allen

I do not know exactly what recurrent means. You can not have been on ADT for more than something like three months but I don't know if that applies to recurrent? You can call and they will guide you through figuring out if you qualify.

Tall_Allen profile image
Tall_Allen in reply tospencoid2

Recurrent is your situation. It means you have received some therapy that attempted to cure you, but didn't.

spencoid2 profile image
spencoid2 in reply toTall_Allen

they only asked about my current ADT did not ask about previous treatments but maybe would have if my case had been different. anyway i did not qualify because i have been on ADT/orchiectomy for over 6 months.

mrscruffy profile image
mrscruffy

The FDA in this country is a slow grind, wife and I have a war chest and contingency plan for treatment in Europe should the need arise. Month in Europe doesn't sound too bad

Echotango51 profile image
Echotango51

Mandrake248, I agree with you. Why wait for other treatments to fail. I have been on lupron for over 5 years. I asked my MO about these treatments, why put a patient through chem and all the ADT drugs, by that time the PC has advanced more. Skip bases 1-3 and go to home plate.

I ran across this: shebaonline.org/treatment/l...

Brysonal profile image
Brysonal

I was told I would qualify for PSMAddition when I was systemic therapy/ hormone naive and my HIFU had failed. However it didn't start early enough in the UK and too urgent for me me to get on hormones. I was told 45 days prior to randomisation was all that was allowed.

clinicaltrials.gov/ct2/show...

So hormone sensitive was not enough but hormone/ systemic treatment naive was.

I went overseas for a private option 10 days after starting hormones therefore.

lewicki profile image
lewicki in reply toBrysonal

University of Heidelberg. AC-225 and LU-177.

j-o-h-n profile image
j-o-h-n

The rabbit in your hat has all the answers....

Good Luck, Good Health and Good Humor.

j-o-h-n Monday 03/28/2022 6:16 PM DST

Not what you're looking for?

You may also like...

Overall Survival With [177]Lu-PSMA-617 vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer

The Lancet Oncology TAKE-HOME MESSAGE TheraP was a phase II trial that compared the efficacy of...
Magnus1964 profile image

Phase 3 trial 177-Lu-PSMA-617

Is anyone in the in the Phase 3 trial going on at UCSF & Stanford that started in 2018 that will...
Bubasurf6 profile image

My experience with Lu-177

Dear fellows in misfortune. I’d like express here my experience with the LU-177 PSMA-617. Diagnosed...
Loujaro profile image

"Right To Try" law and Lu-177

President Trump signed a nationwide law into effect that might provide a pathway to treatment with...
Fairwind profile image

HIF-1α inhibition by DES.

New study below. We are 30+ years into the Lupron era, but diethylstilbestrol [DES] was used for...
pjoshea13 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.